Xencor (XNCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 05/06/24
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical UpdateBusiness Wire • 02/20/24
Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?Zacks Investment Research • 02/19/24
Xencor (XNCR) Earnings Expected to Grow: What to Know Ahead of Q4 ReleaseZacks Investment Research • 02/15/24
Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 MillionBusiness Wire • 11/07/23
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual MeetingBusiness Wire • 11/03/23
Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023Business Wire • 10/31/23